You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Two AstraZeneca therapies accepted in Scotland

AstraZeneca has announced that Tezspire, used for severe asthma, and Forxiga, used to treat chronic heart failure, have been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC).